Spero Therapeutics(DE:2HA)
€0.92+0.03 (+3.59%)
DE:2HA
Spero Therapeutics ownership
€0.92
At close:+0.03 (+3.59%)
Spero Therapeutics (2HA) Ownership - Who Owns Spero Therapeutics?
2 Followers
Spero Therapeutics (2HA) Ownership Overview
- 4.23% Insiders
- 4.40% Mutual Funds
- 16.25% Other Institutional Investors
- 4.05% ETFs
- 71.08% Public Companies and Individual Investors
The ownership structure of Spero Therapeutics (DE:2HA) stock is a mix of institutional, retail, and individual investors. Approximately 24.69% of the company’s stock is owned by Institutional Investors, 4.23% is owned by Insiders, and 71.08% is owned by Public Companies and Individual Investors.
The ownership structure of Spero Therapeutics (DE:2HA) stock is a mix of institutional, retail, and individual investors. Approximately 24.69% of the company’s stock is owned by Institutional Investors, 4.23% is owned by Insiders, and 71.08% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Nov 09, 2026 | Esther Rajavelu | $42,485 | |
| May 05, 2026 | Esther Rajavelu | $63,352 | |
| Feb 08, 2026 | Esther Rajavelu | $207,484 | |
| Feb 08, 2026 | Timothy Keutzer | $44,019 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 1,989,230 | Institution | 3.42% | 2,038,961 |
| Vanguard Index Funds | 1,989,230 | Institution | 3.42% | 2,038,961 |
| Esther Rajavelu | 946,000 | Insider | 1.62% | 969,650 |
| Timothy Keutzer | 742,506 | Insider | 1.28% | 761,069 |
| BlackRock, Inc. | 594,404 | Institution | 1.02% | 609,264 |
| Bruce Winson | 421,956 | Institution | 0.72% | 432,505 |
| Fidelity Concord Street Trust | 249,228 | Institution | 0.43% | 255,459 |
| Invesco | 163,371 | Institution | 0.28% | 167,455 |
| Debra Zack | 162,311 | Insider | 0.28% | 166,369 |
| Ishares | 137,273 | Institution | 0.24% | 140,705 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 1,989,230 | Institution | 3.42% | 2,038,961 |
| Fidelity Concord Street Trust | 249,228 | Institution | 0.43% | 255,459 |
| Bridgeway Funds, Inc. | 114,800 | Institution | 0.20% | 117,670 |
| Dfa Investment Dimensions Group Inc | 69,505 | Institution | 0.12% | 71,243 |
| Forum Funds Ii | 56,457 | Institution | 0.10% | 57,868 |
| Schwab Capital Trust | 28,565 | Institution | 0.05% | 29,279 |
| Vanguard Valley Forge Funds | 24,176 | Institution | 0.04% | 24,780 |
| Vanguard Institutional Index Funds | 22,820 | Institution | 0.04% | 23,390 |
| Victory Portfolios Iii | 9,021 | Institution | 0.02% | 9,247 |
FAQ
Who Owns Spero Therapeutics (DE:2HA)?
According to the latest TipRanks data, approximately 24.69% of the company's stock is held by institutional investors, 4.23% is held by insiders, and 71.08% is held by public companies and individual investors.
What percentage of Spero Therapeutics (DE:2HA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 24.69% of Spero Therapeutics (DE:2HA) stock is held by institutional investors: 4.40% by mutual funds, 4.05% by ETFs and 16.25% by other institutional investors.
What percentage of Spero Therapeutics (DE:2HA) stock is held by retail investors?
According to the latest TipRanks data, approximately 71.08% of Spero Therapeutics (DE:2HA) stock is held by public companies and individual investors.
Who owns the most shares of Spero Therapeutics (DE:2HA)?
Vanguard owns the most shares of Spero Therapeutics (DE:2HA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
